1. Ji XW, Feng GF, Li HL, Fang J, Wang J, Shen QM, et al. Gender differences of relationship between serum lipid indices and type 2 diabetes mellitus: A cross-sectional survey in Chinese elderly adults. Ann Transl Med. 2021;9(2). [
Link] [
DOI:10.21037/atm-20-2478]
2. Khan MAB, Hashim MJ, King JK, Govender RD, Al Kaabi J. Epidemiology of type 2 diabetes - Global burden of disease and forecasted trends. J Epidemiol Glob Health. 2020;10(1):107-11. [
Link] [
DOI:10.2991/jegh.k.191028.001]
3. Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, ho NH, et al. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40-50. [
Link] [
DOI:10.1016/j.diabres.2017.03.024]
4. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047-1053. [
Link] [
DOI:10.2337/diacare.27.5.1047]
5. American Diabetes Association. Classification and diagnosis of diabetes. Diabetes Care. 2015;38:S8-16. [
Link] [
DOI:10.2337/dc15-S005]
6. American Diabetes Association. Classification and diagnosis of diabetes: Standards of medical care in diabetes-2020. Diabetes Care. 2020;43(1):S14-31. [
Link] [
DOI:10.2337/dc20-S002]
7. Viigimaa M, Sachinidis A, Toumpourleka M, Koutsampasopoulos K, Alliksoo S, Titma T (2020). Macrovascular complications of type 2 diabetes mellitus. Curr Diabetes Rev. 18(2):110-6. [
Link] [
DOI:10.2174/1570161117666190405165151]
8. Wang L, Gao P, Zhang M, Huang Z, Zhang D, Deng Q, et al. Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013. J Am Med Assoc. 2017;317(24):2515-23. [
Link] [
DOI:10.1001/jama.2017.7596]
9. Tishkowski K, Gupta V. Erythrocyte Sedimentation Rate. Bethesda: National Library of Medicine; 2023. [
Link]
10. Jialal I, Singh G. Management of diabetic dyslipidemia: An update. World J Diabetes. 2019;10:280-90. [
Link] [
DOI:10.4239/wjd.v10.i5.280]
11. Liu L, Guan X, Yuan Z, Zhao M, Li Q, Zhang X, et al. Different contributions of dyslipidemia and obesity to the natural history of type 2 diabetes: 3-Year cohort study in China. J Diabetes Res. 2019;2019:4328975. [
Link] [
DOI:10.1155/2019/4328975]
12. Zhang M, Zhou J, Liu Y, Sun X, Luo X, Han C, et al. Risk of type 2 diabetes mellitus associated with plasma lipid levels: The rural Chinese cohort study. Diabetes Res Clin Pract. 2018;135:150-7. [
Link] [
DOI:10.1016/j.diabres.2017.11.011]
13. Rizzo M, Rini GB, Berneis K. The clinical relevance of LDL size and subclasses modulation in patients with type-2 diabetes. Exp Clin Endocrinol Diabetes. 2007;115(8):477-82. [
Link] [
DOI:10.1055/s-2007-980179]
14. Kruit JK, Brunham LR, Verchere CB, Hayden MR, et al. HDL and LDL cholesterol significantly influence beta-cell function in type 2 diabetes mellitus. Curr Opin Lipidol. 2010;21(3):178-85. [
Link] [
DOI:10.1097/MOL.0b013e328339387b]
15. Cochran BJ, Ong KL, Manandhar B, Rye KA. High Density Lipoproteins and Diabetes. Cells. 2021:10(4);850. [
Link] [
DOI:10.3390/cells10040850]
16. Sheng G, Liu D, Kuang M, Zhong Y, Zhang S, Zou Y. Utility of non-high density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio in evaluating incident diabetes risk. Diabetes Metab Syndr Obes: Targets Ther. 2022;15:1677-86. [
Link] [
DOI:10.2147/DMSO.S355980]
17. Wu D, Lan Y, Xu Y, Xu S, Huang Y, Balmer L, et al. Association of cumulative monocytes to high-density lipoprotein ratio with the risk of type 2 diabetes: a prospective cohort study. Cardiol Diabetol. 2022;21(1):268. [
Link] [
DOI:10.1186/s12933-022-01701-7]
18. Ishibashi T, Kaneko H, Matsuoka S, Suzuki Y, Ueno K, Ohno R, et al. HDL cholesterol and clinical outcomes in diabetes mellitus: A systematic review and meta-analysis. Eur J Prev Cardiol. 2023;30(8):646-53. [
Link] [
DOI:10.1093/eurjpc/zwad029]
19. Wang Y, Yang P, Yan Z, Liu Z, Ma Q, Zhang Z, et al. The relationship between erythrocytes and diabetes mellitus. J Diabetes Res. 2021:6656062. [
Link] [
DOI:10.1155/2021/6656062]
20. Kiyani MM, Jahan S, Kiani SK, Rehman H, Khan LG, Iqbal U. Erythrocyte sedimentation rate in diabetic and non-diabetic patients of cardiovascular disease. J Technol Lab. 2019;8(1):18-22. [
Link] [
DOI:10.29238/teknolabjournal.v8i1.159]
21. Kaleta JL, Fleischli JW, Reilly CH. The diagnosis of osteomyelitis in diabetes using erythrocyte sedimentation rate: A pilot study. J Am Podiatr Med Assoc. 2001;9(9):445-50. [
Link] [
DOI:10.7547/87507315-91-9-445]
22. Guo S, Wang M, Yu Y, Yang Y, Zeng , Sun F, et al. The association of erythrocytes sedimentation rate, high-sensitivity creativity protein and diabetic kidney disease in patients with type 2 diabetes. BMC Endocr Disord. 2020;13(20):103. [
Link] [
DOI:10.1186/s12902-020-00584-7]
23. Feng Q, Wei WQ, Chung CP, Levinson RT, Sondermann AC, Mosley JD, et al. Relationship between very low low-density lipoprotein cholesterol concentrations not due to statin therapy and risk of type 2 diabetes: A US-based cross-sectional observational study using electronic health records. PLOS Med. 2018;15(8):e1002642. [
Link] [
DOI:10.1371/journal.pmed.1002642]
24. Janghorbani M, Soltanian N, Amini M, Aminorroaya A. Low-density lipoprotein cholesterol and risk of type 2 diabetes: The Isfahan Diabetes Prevention Study. Diabetes Metab Syndr: Clin Res Rev. 2010;12(5):715-19. [
Link] [
DOI:10.1016/j.dsx.2018.04.019]
25. Prenner SB, Mulvey CK, Ferguson JF, Rickels MR, Bhatt AB, Reilly MP. Very low density lipoprotein cholesterol associates with coronary artery calcification in type 2 diabetes beyond circulating levels of triglycerides. Atherosclerosis. 2014;236(2):321-26. [
Link] [
DOI:10.1016/j.atherosclerosis.2014.07.008]
26. Jin JL, Zhang HW, Cao YX, Liu HH, Hua Q, Li YF, et al. Association of small dense low-density lipoprotein with cardiovascular outcome in patients with coronary artery disease and diabetes: a prospective, observational one cohort study. Cardiovasc Diabetol. 2020;19(1):45. [
Link] [
DOI:10.1186/s12933-020-01015-6]
27. Ye X, Kong W, Zafar MI, Chen LL. Serum triglycerides as a risk factor for cardiovascular diseases in type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies. Cardiovasc Diabetol. 2019;18(48). [
Link] [
DOI:10.1186/s12933-019-0851-z]
28. Beshara A, Cohen E, Goldberg E, Lilos P, Garty M, Krause I. Triglyceride levels and risk of type 2 diabetes mellitus: A longitudinal large study. J Investig Med. 2016;64(2).383-7. [
Link] [
DOI:10.1136/jim-2015-000025]
29. Su WY, Chen SC, Huang YT, Huang JC, Wu PY, Hsu WH, et al. Comparison of the effects of fasting glucose, hemoglobin A1c, and triglyceride-glucose index on cardiovascular events in type 2 diabetes mellitus. Nutrients. 2019;11(11):2838. [
Link] [
DOI:10.3390/nu11112838]
30. Zheng D, Dou J, Liu G, Pan Y, Yan Y, Liu F, et al. Association between triglyceride level and glycemic level control among insulin-treated patients with type 2 diabetes. J Clin Endocrinol Metab. 2019;104(4):1211-20. [
Link] [
DOI:10.1210/jc.2018-01656]
31. Simonen PP, Gylling HK, Miettinen TA. Diabetes contributes to cholesterol metabolism regardless of obesity. Diabetes Care. 2002;25(9):1511-15. [
Link] [
DOI:10.2337/diacare.25.9.1511]
32. Rhee EJ, Han K, Ko SH, Ko KS, Lee WY. Increased risk for diabetes development in subjects with large variation in total cholesterol levels in 2,827,950 Koreans: A nationwide population-based study. PLoS ONE. 2017;12(5):e0176615. [
Link] [
DOI:10.1371/journal.pone.0176615]
33. Li Y, Pei H, Zhou C, Lou Y. Dietary cholesterol consumption and incidence of type 2 diabetes mellitus: A dose-response meta-analysis of prospective cohort studies. Nutr Metab Cardiovasc Dis. 2023;33(1):2-10. [
Link] [
DOI:10.1016/j.numecd.2022.07.016]
34. Peng J, Zhao F, Yang X, Pan X, Xin J, Wu M, et al. Association between dyslipidemia and risk of type 2 diabetes mellitus in middle-aged and older Chinese adults: a secondary analysis of a nationwide cohort. BMJ Open. 2021;11(5):e042821. [
Link] [
DOI:10.1136/bmjopen-2020-042821]